ALB and hepatocellular carcinoma: The Albumin-Bilirubin (ALBI) score, originally proposed by Johnson et al. as a model to assess liver function in patients with hepatocellular carcinoma (HCC), has shown limited predictive power for the prognosis of ACLF (4).